Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

236.98
Delayed Data
As of Apr 24
 +0.63 / +0.27%
Today’s Change
184.50
Today|||52-Week Range
261.27
+12.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-749.7M-1.6B3.9B15.0B
 
 
 
 
 
Depreciation1.0B2.8B5.6B6.6B
 
 
 
 
 
Total Other Cash Flow1.4B2.2B3.7B-18.0B
 
 
 
 
 
Funds From Operations1.4B2.7B5.8B2.2B
 
 
 
 
 
Funds From/For Other Operating Expenses163.6M431.9M1.3B726.5M
 
 
 
 
 
Net Cash Flow - Operating Activities1.2B2.2B4.5B1.4B
 
 
 
 
 
 
InvestingIncrease In Investments0.00-1.0M-24.3M-15.7B
 
 
 
 
Decrease In Investments33.2M12.0M883.0M0.00
 
 
 
 
Capital Expenditures-177.9M-238.6M-454.9M-331.4M
 
 
 
 
 
Fixed Asset Disposal11.6M13.7M140.1M33.8B
 
 
 
 
 
Net Assets From Acquisitions -15.1M-5.6B-37.5B-1.2B
 
 
 
 
 
Other Investing - Sources2.9M441.7M--7.8B
 
 
 
 
Net Cash Flow Investing-275.3M-5.4B-37.1B24.3B
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00------
Long Term Borrowings2.4B9.1B29.8B1.1B
 
 
 
 
 
Long Term Debt Reduction-3.2B-6.1B-5.1B-10.8B
 
 
 
 
 
Net Proceeds Stock Sale48.0M105.9M9.2B172.1M
 
 
 
 
 
Common Preferred Redeemed-170.0M-130.1M-118.0M-15.1B
 
 
 
 
 
Common Dividends0.000.00-208.1M0.00
 
 
Cash Dividends Paid - Total0.000.00-208.1M-278.4M
 
 
 
Other Sources - Financing69.0M51.1M76.1M20.4M
 
 
 
 
 
Other Uses - Financing14.7M14.3M230.1M161.1M
 
 
 
 
 
Net Cash Flow - Financing-867.3M3.0B33.4B-25.1B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-60.9M-5.9M-6.5M-8.5M
 
 
 
 
 
 
Net Change In Cash70.9M-110.1M852.5M636.5M